NGF SIGNALING IN MODELS OF AGE RELATED NEURODEGENERATION
年龄相关神经退行性变模型中的 NGF 信号传导
基本信息
- 批准号:6533821
- 负责人:
- 金额:$ 32.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-09-15 至 2005-08-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer's disease Downs syndrome acetylcholine aging apolipoprotein E biological signal transduction confocal scanning microscopy gene targeting genetic models genetically modified animals growth factor receptors laboratory mouse neural degeneration neuropathology neurotrophic factors prosencephalon protein transport tissue /cell culture
项目摘要
The broad long-term goal is to elucidate the mechanisms responsible for
the dysfunction and loss of neurons in degenerative neurological
disorders. In Alzheimer's disease (AD) and Down syndrome (DS), age-
related degeneration of basal forebrain cholinergic neurons (BFCNs)
contributes significantly to dementia. Defining the molecular events
leading to BFCN degeneration would significantly advance our
understanding of pathogenesis. In studies on the Ts65Dn mouse, a
genetic model for DS, we documented age-related degeneration of BFCNs.
Nerve growth factor (NGF) is essential to the function of normal BFCNs
and recent findings suggest that failed NGF signaling contributes to
their degeneration of Ts65Dn. We will test the hypothesis: that a
failure in NGF signaling is responsible for the degeneration (i.e.
progressive dysfunction) of BFCNs in the Ts65Dn mouse. The proposed
Specific Aims are: 1) To characterize the functional status of BFCNs and
document age-related dysfunction of these neurons in Ts65Dn mice. Using
unbiased stereology, biochemical and behavioral studies we will document
the time of onset of BFCN dysfunction in Ts65Dn mice. 2) To determine
if NGF signaling is defective in BFCNs in Ts65Dn and, if so, to
determine whether the abnormality predate degeneration of BFCNs.
Abnormal NGF retrograde transport will be used to document the existence
of a signaling defect and biochemical studies will define its nature and
time of onset. 3) To determine whether disrupting NGF signaling
reproduces the cholinergic abnormalities seen in Ts65Dn. If the NGF
signaling defect demonstrated in Aim 2 is sufficient to produce the
degeneration of BFCNs in Ts65Dn, animals defective for NGF signaling
should show the same degenerative events. We will examine mice treated
with NGF antibodies to sequester endogenous NGF, mice in which one copy
of the NGF gene has been disrupted, and mice in which both copies of the
gene for the NGF TrkA receptor has been knocked-out. 4) To define NGF
actions on degenerating BFCNs in Ts65Dn. Current data suggest that NGF
may be capable of reversing other aspects of BFCN degeneration. In this
Aim, we will determine whether NGF reverses the degenerative phenotypes
defined in Aim 1. 5) To determine whether BFCN degeneration is found
in other genetic models of Ds and AD and, if so, whether failed NGF
signaling is present. We will examine BFCNs in several models of AD.
If BFCN atrophy is detected, we will determine whether there is an
abnormality of NGF signaling. We will also examine Ts65Dn animals
expressing either human Apo E3 or E4 to determine whether, as expected,
BFCN degeneration is worse in ApoE4 expressing mice. Evidence that
abnormal NGF signaling is responsible for BFCN degeneration in models
of AD and DS will give important new insights into pathogenesis and may
suggest novel approaches to prevent or reverse dementia in these
patients.
广泛的长期目标是阐明负责的机制
退化神经系统中神经元的功能障碍和丧失
疾病。 在阿尔茨海默氏病(AD)和唐氏综合症(DS)中,年龄 -
基础前脑胆碱能神经元(BFCN)的相关变性
对痴呆症有重大贡献。 定义分子事件
导致BFCN变性将大大推动我们的
对发病机理的理解。 在TS65DN小鼠的研究中
DS的遗传模型,我们记录了BFCN与年龄相关的变性。
神经生长因子(NGF)对于正常BFCN的功能至关重要
最近的发现表明,失败的NGF信号导致
他们的TS65DN退化。 我们将检验以下假设:
NGF信号失败是导致变性的(即
TS65DN小鼠中BFCN的进行性功能障碍。 提议
具体目的是:1)表征BFCN的功能状态和
这些神经元在TS65DN小鼠中与年龄相关的功能障碍。 使用
公正的立体学,生化和行为研究我们将记录
TS65DN小鼠中BFCN功能障碍的发作时间。 2)确定
如果NGF信号在TS65DN中的BFCN中有缺陷,则为
确定异常是否早于BFCN的变性。
NGF异常逆行运输将用于记录存在
信号缺陷和生化研究将定义其性质和
发作时间。 3)确定是否破坏NGF信号传导
再现TS65DN中看到的胆碱能异常。 如果是NGF
AIM 2中证明的信号传导缺陷足以产生
TS65DN中BFCN的变性,动物在NGF信号中有缺陷
应该显示相同的退行性事件。 我们将检查接受治疗的小鼠
使用NGF抗体隔离内源性NGF,其中一个拷贝
NGF基因已被破坏,并且两种副本的小鼠
NGF TRKA受体的基因已被淘汰。 4)定义NGF
在TS65DN中对BFCN进行退化的作用。 当前数据表明NGF
可能能够逆转BFCN变性的其他方面。 在这个
目的,我们将确定NGF是否逆转退化表型
在目标1。5)中定义为确定是否发现BFCN变性
在其他DS和AD的遗传模型中,如果是的,则NGF是否失败
存在信号。 我们将在几种AD模型中检查BFCN。
如果检测到BFCN萎缩,我们将确定是否存在
NGF信号传导异常。我们还将检查TS65DN动物
表达人apo e3或e4以确定是否按预期
APOE4表达小鼠的BFCN变性较差。 证据
异常NGF信号导致模型中的BFCN变性
AD和DS将为发病机理提供重要的新见解,可能
提出了预防或反向痴呆的新方法
患者。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Neonatal mouse cardiac myocytes exhibit cardioprotection induced by hypoxic and pharmacologic preconditioning and by transgenic overexpression of human Cu/Zn superoxide dismutase.
新生小鼠心肌细胞表现出由缺氧和药理预处理以及人铜/锌超氧化物歧化酶转基因过度表达诱导的心脏保护作用。
- DOI:10.1006/jmcc.2000.1212
- 发表时间:2000
- 期刊:
- 影响因子:5
- 作者:Karliner,JS;Honbo,N;Epstein,CJ;Xian,M;Lau,YF;Gray,MO
- 通讯作者:Gray,MO
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William C Mobley其他文献
William C Mobley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William C Mobley', 18)}}的其他基金
Antisense Oligonucleotides targeting APP to prevent neurodegeneration in models of Down Syndrome and Alzheimer's disease
靶向 APP 的反义寡核苷酸可预防唐氏综合症和阿尔茨海默病模型中的神经变性
- 批准号:
10554249 - 财政年份:2019
- 资助金额:
$ 32.62万 - 项目类别:
Antisense Oligonucleotides targeting APP to prevent neurodegeneration in models of Down Syndrome and Alzheimer's disease
靶向 APP 的反义寡核苷酸可预防唐氏综合症和阿尔茨海默病模型中的神经变性
- 批准号:
10543710 - 财政年份:2019
- 资助金额:
$ 32.62万 - 项目类别:
Antisense Oligonucleotides targeting APP to prevent neurodegeneration in models of Down Syndrome and Alzheimer's disease
靶向 APP 的反义寡核苷酸可预防唐氏综合症和阿尔茨海默病模型中的神经变性
- 批准号:
9905472 - 财政年份:2019
- 资助金额:
$ 32.62万 - 项目类别:
Antisense Oligonucleotides targeting APP to prevent neurodegeneration in models of Down Syndrome and Alzheimer's disease
靶向 APP 的反义寡核苷酸可预防唐氏综合症和阿尔茨海默病模型中的神经变性
- 批准号:
10334410 - 财政年份:2019
- 资助金额:
$ 32.62万 - 项目类别:
Antisense Oligonucleotides targeting APP to prevent neurodegeneration in models of Down Syndrome and Alzheimer's disease
靶向 APP 的反义寡核苷酸可预防唐氏综合症和阿尔茨海默病模型中的神经变性
- 批准号:
10092057 - 财政年份:2019
- 资助金额:
$ 32.62万 - 项目类别:
Treating with Gamma-Secretase Modulators to Prevent Neurodegeneration in Mouse Models of Down Syndrome and Alzheimer Disease
使用γ-分泌酶调节剂治疗以预防唐氏综合症和阿尔茨海默病小鼠模型的神经退行性变
- 批准号:
10338158 - 财政年份:2018
- 资助金额:
$ 32.62万 - 项目类别:
Genetic Basis of Failed Cognition in Young and Aged Mouse Models of Trisomy 21
21 三体年轻和老年小鼠模型认知失败的遗传基础
- 批准号:
8145581 - 财政年份:2010
- 资助金额:
$ 32.62万 - 项目类别:
Genetic Basis of Failed Cognition in Young and Aged Mouse Models of Trisomy 21
21 三体年轻和老年小鼠模型认知失败的遗传基础
- 批准号:
8725237 - 财政年份:2010
- 资助金额:
$ 32.62万 - 项目类别:
相似海外基金
NGF SIGNALING IN MODELS OF AGE RELATED NEURODEGENERATION
年龄相关神经退行性变模型中的 NGF 信号传导
- 批准号:
6492635 - 财政年份:1998
- 资助金额:
$ 32.62万 - 项目类别:
NGF SIGNALING IN MODELS OF AGE RELATED NEURODEGENERATION
年龄相关神经退行性变模型中的 NGF 信号传导
- 批准号:
6372364 - 财政年份:1998
- 资助金额:
$ 32.62万 - 项目类别:
NGF SIGNALING IN MODELS OF AGE RELATED NEURODEGENERATION
年龄相关神经退行性变模型中的 NGF 信号传导
- 批准号:
6055500 - 财政年份:1998
- 资助金额:
$ 32.62万 - 项目类别:
NGF SIGNALING IN MODELS OF AGE RELATED NEURODEGENERATION
年龄相关神经退行性变模型中的 NGF 信号传导
- 批准号:
6169599 - 财政年份:1998
- 资助金额:
$ 32.62万 - 项目类别:
NGF SIGNALING IN MODELS OF AGE RELATED NEURODEGENERATION
年龄相关神经退行性变模型中的 NGF 信号传导
- 批准号:
2866835 - 财政年份:1998
- 资助金额:
$ 32.62万 - 项目类别: